464109879 | bhmh | 29069517 | | 3001570 | 7/7/2006 12:00:00 am | diastolic dysfunction-chf | | dis | admission date: 8/13/2006 report status:discharge date: 10/16/2006 final discharge orders amancio , leopoldo 386-98-18-5tari uservice: cardischarge patient on: 7/10/06 at 01:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: errington , gregg t. , m.d.code status:full codedisposition: homedischarge medications:acetylsalicylic acid 81 mg po dailylipitor ( atorvastatin ) 40 mg po dailystarting give at dischargeinstructions: pt's home med-has prescriptioncolace ( docusate sodium ) 100 mg po bidferrous gluconate 325 mg po tidfood/drug interaction instruction avoid milk and antacidlasix ( furosemide ) 40 mg po bidkcl slow release 20 meq po dailyas per buohc potassium chloride policy:each 20 meq dose to be given with 4 oz of fluidalert overridden: override added on 7/10/06 bystrasser , tod , m.d. , m.p.h.potentially serious interaction: lisinopril & potassiumchloridepotentially serious interaction: lisinopril & potassiumchloride reason for override: md awarelisinopril 15 mg po dailyoverride notice: override added on 7/10/06 bymallinger , osvaldo , m.d. , m.p.h.on order for kcl slow release po ( ref # 170907436 )potentially serious interaction: lisinopril & potassiumchloridepotentially serious interaction: lisinopril & potassiumchloride reason for override: md awareprevious override information:override added on 5/28/06 by :potentially serious interaction: potassium chloride &lisinoprilpotentially serious interaction: potassium chloride &lisinopril reason for override: pts home medprevious alert overridden override added on 8/27/06 by :potentially serious interaction: potassium chloride &lisinoprilpotentially serious interaction: potassium chloride &lisinopril reason for override: md awareprevious override noticeoverride added on 8/27/06 by schlegel , samuel , m.d. , m.p.h.on order for kcl immediate release po ( ref #701631300 )potentially serious interaction: lisinopril & potassiumchloridepotentially serious interaction: lisinopril & potassiumchloride reason for override: md awaretoprol xl ( metoprolol succinate extended release )25 mg po daily starting today ( 11/9 )food/drug interaction instructiontake consistently with meals or on empty stomach.number of doses required ( approximate ): 4paxil ( paroxetine ) 20 mg po dailydiet: house / low chol/low sat. fatactivity: walking as toleratedfollow up appointment( s ):pcp-dr. bussard 10/10/06 ,cardiologist-dr. mercik 8/18/06 ,allergy: penicillinsadmit diagnosis:lightheadedness/shortness of breathprincipal discharge diagnosis ;responsible after study for causing admission )diastolic dysfunction-chfother diagnosis;conditions , infections , complications , affecting treatment/stayhypertension ( hypertension ) dyslipidemia ( dyslipidemia ) coronaryartery ( coronary artery disease ) tobacco , anxietyoperations and procedures:other treatments/procedures ( not in o.r. )stress test with oximetry to assess cardiopulmonary statusecho ( tte )brief resume of hospital course:cc: lightheadness and doehpi: 78 y.o female with a past medical hx significant for cad s/p cabg in4/25 ( lima to lad with saphenous vein graft to lm1 and svg to pda ). pthas been having intermittent episodes of doe , extending back before hercabg , usually exertional in nature. pt denies cp , however she tends tohyperventilate during these episodes which makes her lightheaded. pt alsodenied syncope , palpitations , changes in vison/hearing , or weakness.these episodes have recently been increasing in frequency occuring up to4x/day but she denied any temporal relationship. on the day ofadmission , pt had an episode while going from the bed to the bathroom soshe came to the ed.in the ed , bp 148/67 , hr 72 , sao2 94 ra.pmh: 1. cad s/p cabg 4/25lima -> lad , svg -> om , svg -> pda2. htn3. hyperlipidemia4. anxietymeds on admission:aspirin 325mg qdtoprol xl 25mg qdlasix 20mg qdlisinopril 5mg qdpaxil 20mg qdall: pcn-anaphylaxisfh: neg cadsh:pcp: dr. bault , / cardiologist- dr. petraglia ,px on admissionvss-bp: 128/72 , p: 70 , so2: 96% ragen: well-nourished female lying in bed , nadcv: rrr s1/s2 -mrgresp: ctababd: soft non-tender + bsext: warm , neg edemalabs:wbc: 9.1 , hb: 15 , hct: 35.4 , plt: 280mcv: low at 76.5-79.5romi x 3 negative , trop <assayekg: nsr infralateral t wave inversion unchanged from priorhospital course:1. cv - pt was romi x3 neg , kept on tele-however no events , stress testwith oximetry was done on 3/2 , echo 4/12 showed diastolicdysfunctionhtn: pt had occasional increased bp readings 160/90;increased lisinopril to 15mg on 10/3 goal bp was < 130/802. endo - tsh low at 0.439 , t4/t3 normal , hba1c: elevated 8.23. psych - continued paxil , have added ativan 0.5mg bid prn4. heme: mcv is low , fe: 39 low , tibc 365 ferritin 85; most likely irondeficiency anemia--given ferrous gluconate/colace on discharge5. code - fulldischarge px:vss: t: 97.8 , p: 60-82 , bp: 138-160/72-92 , bp at discharge 130/70so2: 95-100% radischarge labs:na: 142 , k 4.o , cl: 107 , co2: 26 , bun: 19 , creat: 0.8wbc: 10.5 , hb: 11.8 , hct: 35.8 , plt: 297 , mcv: 78.0alkp: 120additional comments: ms. dinwoodie it was a pleasure to take care of you during yourhospitalization. we have made some changes to your medications. weincreased your blood pressure medication: lisinopril from 5mg to 15mgonce a day. we started you on a medication for anemia: ferrousgluconate which you should take 3 times a day along with colace a stoolsoftener which you should take twice a day. we also increased your lasixfrm 20mg once a day to 40mg twice a day. as discussed with you , yourechocardiogram ( ultrasound of your heart ) showed that you had someabnormality with the functioning of your heart which may in part explainyour shortness of breath especially on exertion. it is extremely importantto follow up with your primary care physician dr. clague appt 7/12 at12:10pm and your cardiologist dr. dodgen on 2/16 at 1:30pm. if youhave trouble breathing , have chest pain please seek medical attention assoon as possible.discharge condition: stableto do/plan:f/u tsh , t4/t3 , hba1c is elevated; will need hyperglycemic agentf/u iron studies mcvf/u alk phosevent monitor will be sent to pt in 7-10 business daysno dictated summaryentered by: voorhis , isaac , m.d. , m.p.h. ( rz46 ) 7/10/06 @ 12 end of discharge orders 